ANCA associated Vasculitis
MICROBIOME
- IMP: Nasal microbiome
- The Microbiome Study – Health Research Authority (opens in a new tab)
COMBIVAS Biomarker Study (Sample ethics)
- IMP: Rituximab with belimumab compared to rituximab with placebo
EME NIHR134720 (G111920)
- IMP: Rituximab
IRVAS
- IMP: Immunohistological research
- Immunohistological Research in Primary Systemic Vasculitis (IRVAS) – Health Research Authority (opens in a new tab)
Immunodeficiency
COVID-19 Antibody Responses
- IMP: SARS CoV-2 IgG antibodies
- COVID-19 antibody responses in immunocompromised patients - Health Research Authority (opens in a new tab)
VARIED (sample ethics for ACQ and PRO V)
- IMP: Vaccine Responses to understand Immune Dysfunction
- Vaccine Responses to understand Immune Dysfunction: VARIED study - Health Research Authority (opens in a new tab)
SLE/lupus nephritis
3TR
- IMP: Biomarker study
- 3TR SLE - Health Research Authority (opens in a new tab)